Head to Head
Amble vs Belle Health
Both hold one rate at every dose, but Belle Health names the pharmacies that compound its medication and Amble publishes almost nothing beyond a starting-at price.
At a glance
| Compared on | Amble | Belle Health |
|---|---|---|
| Pricing structure | One rate per drug, published as a starting-at figure | One rate per drug, holding at every dose |
| Plan commitment | No plan term published | The bundled tirzepatide rate requires three months; the semaglutide rate carries no bundle |
| Compounding pharmacy | Not named | More than one named on the site |
| Medications offered | Compounded semaglutide and compounded tirzepatide | Compounded semaglutide and compounded tirzepatide |
| Brand-name option | None published | None published |
| States served | All fifty states | All fifty states |
| What the price covers | Medication, injection supplies, and delivery, per Amble's own wording | Membership includes a weekly session with a registered dietitian |
| Regulatory disclosures | No FDA warning letter | One FDA warning letter, February 2026, about how Belle's site presented Belle branding beside the compounded drugs it sells |
| Disclosure depth | Price and state availability; no pharmacy name, no accreditation seal, no published intake or cancellation terms | Names more than one compounding pharmacy, which is unusual in this category |
| Disclosure score | 5.0/10 | 7.5/10 |
What each one publishes
| Medication | Amble | Belle Health |
|---|---|---|
| Semaglutide (compounded) | $179/mostarting at, per monthflat rate, all doses · Verified August 2026 — source | $119/moper monthflat rate, all doses · Verified August 2026 — source |
| Tirzepatide (compounded) | $289/mostarting at, per monthflat rate, all doses · Verified August 2026 — source | $199/moper month, 3-month bundleflat rate, all doses · Verified August 2026 — source |
The structure is the same. The record is not.
Amble and Belle Health price the same way. One rate per drug, and it does not climb as the dose does. That is the shape a reader should want, because dose-tiered pricing raises the bill at the point the medication starts working.
Everything else separates them. Belle Health prints the names of more than one compounding pharmacy. Amble names none. Amble also publishes no accreditation seal, no intake detail, and no cancellation terms. Those four absences are the finding, not a complaint about a website being hard to read.
An absence is not proof that an answer does not exist. A reader who calls Amble may well get one. What a reader cannot do is settle the question before handing over personal information, which is when it matters.
Read Amble's qualifier before you compare the number
Both Amble figures are starting-at prices. On tirzepatide, Amble's own site says the range runs above the figure it leads with. A floor is not a quote.
Set a floor against Belle Health's standing rate and the two are not comparable. Get a quote for your own situation from Amble first, then run the comparison on numbers of the same kind.
Belle Health's tirzepatide figure carries a different condition. It is the bundled rate, and the bundle is three months. A shorter term costs more each month, and Belle publishes that rather than burying it. On semaglutide there is no bundle requirement at all.
Why the pharmacy name carries so much weight here
On a compounded medication, one question outranks the rest: who prepared what is in the vial. Belle Health answers it and names more than one partner. Amble does not answer it.
Naming a pharmacy is not a quality verdict on that pharmacy. It moves the question from unanswerable to answerable, which is the whole value. A reader can look up an entity they can name.
In a thin record the gap is wider than it looks. Amble offers no seal, no named clinical leadership, and no published process detail to weigh instead. Belle Health's disclosure costs it nothing but candor, and it is the clearest difference between these two.
The Belle Health warning letter, stated plainly
Belle Health received FDA warning letter No. 721795, issued in February 2026. It concerned how Belle's website displayed Belle branding alongside the compounded semaglutide and tirzepatide it sells. The agency's position was that the presentation implied Belle itself manufactured those drugs.
That is a matter of marketing and presentation. It is not a finding about the contents of a vial, and it is not reported as one. Amble carries no warning letter.
What a reader can take from it is narrow. Belle has been formally corrected once on how it describes its relationship to the drugs it sells, which is a reason to read its marketing claims literally. Some readers rule out any company with a regulatory action on principle, and that is a legitimate call to make with the letter in front of you.
What both share
Both ship to all fifty states, so availability is unlikely to decide anything between them.
Both sell compounded products only. Compounded semaglutide and tirzepatide are prepared by a compounding pharmacy and are not FDA-approved finished drug products. Neither publishes a brand-name option, so a reader who wants an approved medication is looking at the wrong pair.
So which one
It depends on which of these matters more to you. If you will not buy a compounded medication without knowing which pharmacy made it, Belle Health answers that and Amble does not.
If you are early in a comparison and want a published flat rate with supplies and delivery already inside it, Amble belongs in the table. Just carry its starting-at qualifier with it, and make the call before you enroll rather than after.
Boards both of these appear on
Amble and Belle Health both qualify for 4 of the 6 boards on this site. Each board ranks a wider field than these two, so a position here is against everyone on it, not against each other.
- Semaglutide — Amble #10, Belle Health #1, of 15
- Tirzepatide — Amble #10, Belle Health #2, of 12
- Cheapest Overall — Amble #10, Belle Health #1, of 16
- Insurance-Friendly — Amble #7, Belle Health #1, of 9
Who each one is better for
Amble
- Readers building an early price comparison who want a published flat rate, with supplies and delivery already folded into the figure.
- Patients who expect to titrate up and want the monthly number to stay where it started.
- People willing to call and confirm the pharmacy, the intake, and the cancellation terms rather than expecting to find them published.
Belle Health
- Readers who will not enroll with a provider that refuses to say which pharmacy fills the prescription.
- Patients who will genuinely use an included weekly dietitian session rather than let it lapse.
- Readers who want a firm published rate rather than a starting-at figure, and who can commit three months for the bundled tirzepatide rate.
Frequently asked questions
Which one actually costs less?
That cannot be settled from the headline figures, because they are different kinds of number. Amble publishes starting-at prices, and its own site says the tirzepatide range runs higher than the figure it leads with. Belle Health publishes a firm rate per drug, with a three-month bundle attached to the tirzepatide one. Get a quote from Amble for your own situation, confirm which Belle term applies to you, and compare those two figures rather than the advertised entry points.
Does Belle Health's FDA warning letter mean its medication is unsafe?
No. Letter No. 721795, issued in February 2026, concerned how Belle's website displayed Belle branding next to the compounded semaglutide and tirzepatide it sells. The agency's position was that the presentation implied Belle manufactured those drugs. It is a regulatory action about presentation, not a finding about the contents or quality of what a patient receives. It is disclosed because a reader spending money deserves to know a company has been corrected, and the letter itself is public so you can read the agency's own words.
Does either one name the pharmacy that compounds the medication?
Belle Health does, and it names more than one partner. Amble does not name any, and it displays no third-party accreditation seal either. On a compounded medication that is the disclosure most worth having, because you cannot look up a pharmacy you cannot identify. This is the single largest difference between the two.
Does the price rise as my dose goes up at either one?
No. Both hold one rate per drug across doses, so a titration schedule does not move the monthly figure at either provider. That is the strongest thing Amble and Belle Health have in common. The conditions attached to their rates are where they part: a three-month bundle on Belle's tirzepatide, and a starting-at qualifier on both of Amble's figures.
Can I get Wegovy or Zepbound from either?
No. Both sell compounded semaglutide and tirzepatide only. Compounded preparations are made by a compounding pharmacy and have not been through the FDA approval process a brand-name GLP-1 has. If an approved product is what you want, neither of these two publishes one, and you should be comparing a different set of providers.
compareglp is not affiliated with, endorsed by, or sponsored by Amble or Belle Health. Confirm current pricing and terms on each company's own site before enrolling. Terms used above are defined in the glossary.